Wynnefield Partners Small Cap Value LP's Form 4 filing
Lifecore Biomedical, Inc. DE (LFCR) · filed Oct 26, 2022
- Accession no.
- 0001104659-22-111620
- Filed
- Oct 26, 2022, 6:43 PM ET
- Trade date
- Oct 24, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $2.02M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wynnefield Partners Small Cap Value LPCIK 0000899083 | 10% Owner |
| Obus NelsonCIK 0001017043 | 10% Owner |
| Wynnefield Small Cap Value Offshore Fund LtdCIK 0001030806 | 10% Owner |
| Wynnefield Capital Management LLCCIK 0001056835 | 10% Owner |
| Wynnefield Partners Small Cap Value LP ICIK 0001251565 | 10% Owner |
| Wynnefield Capital IncCIK 0001251567 | 10% Owner |
| Landes JoshuaCIK 0001251568 | 10% Owner |
| Wynnefield Capital, Inc. Profit Sharing PlanCIK 0001289453 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 24, 2022 | Common Stock, $0.001 par value per share | PPurchaseAcquired | +103,000 | $8.09 | +$833,270 | 1,627,593 | Direct | |
| Oct 24, 2022 | Common Stock, $0.001 par value per share | PPurchaseAcquired | +147,000 | $8.09 | +$1,189,230 | 2,155,694 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.